TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
TLPH

Talphera Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ -1.7% vs. previous close Closing price · As of: Sep 29, 2026

Ownership

Ownership Structure

Who owns Talphera Inc. (TLPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.6% of the shares are freely tradable; institutional investors hold 34.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 34.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 21.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 48.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 52Mio.

Largest Shareholders

Institutions

Institutions TLPH
Name Stake (%) Shares Change (%) Date
AIGH Capital Management, LLC 8.87 4,601,502 -1.3 06/30/2026
Rock Springs Capital Management LP 6.91 3,589,186 +0.0 06/30/2026
Nantahala Capital Management, LLC 6.73 3,492,519 +0.0 03/31/2026
Rosalind Advisors, Inc. 6.46 3,353,916 -6.3 03/31/2026
Bleichroeder LP 2.52 1,307,787 +48.4 03/31/2026
CANTOR FITZGERALD, L. P. 1.71 887,481 +53.7 03/31/2026
Caption Management, LLC 1.08 561,820 +0.0 03/31/2026
Almitas Capital LLC 0.90 467,152 +0.0 03/31/2026
Vanguard Capital Management, LLC 0.85 441,611 +0.0 03/31/2026
Dauntless Investment Group, LLC 0.84 435,234 -24.9 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?